Grajales, David http://orcid.org/0000-0002-0611-4549
Le, William T.
Tran, Trang
David, Sandryne
Dallaire, Frédérick
Ember, Katherine
Leblond, Frédéric
Ménard, Cynthia
Kadoury, Samuel
Funding for this research was provided by:
Institut TransMedTech
Article History
Received: 22 January 2024
Accepted: 4 March 2024
First Online: 4 April 2024
Declarations
:
: F. Leblond is co-founder of ODS Medical (now Reveal Surgical) formed in 2015 to commercialize a Raman spectroscopy system for neurosurgical and prostate surgery applications. The other authors declare no conflicts of interest.
: All procedures performed in studies involving human participants, from which data were used in the present research, were in accordance with the ethical standards of the institutional and/or national research committee: (ODS Sentry System-1000/2019-5313), (HS#: STUDY-20-01371), (EAN 2021-5997), (NCT03378856).
: Informed consent was obtained from all individual participants included in the studies.